Type 2 diabetes in children: Clinical aspects and risk factors

Hormone Research

Volumn 57, Issue SUPPL. 1, 2002, Pages 19-28

  Arslanian, Silva ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Children and adolescents; Insulin resistance; Insulin secretion; Type 2 diabetes

Indexed keywords

C PEPTIDE; GROWTH HORMONE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

B LYMPHOCYTE; BODY MASS; CHILDHOOD DISEASE; CLINICAL FEATURE; CONFERENCE PAPER; DISEASE COURSE; ETHNIC GROUP; FAMILY HISTORY; GENDER; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PUBERTY; RISK FACTOR; SYNDROME X;

EID: 0036242419     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000053308     Document Type: Conference Paper

References (114)

1. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The third national health and nutrition examination survey, 1988-1994
2. Prevalence and incidence of non-insulin-dependent diabetes
3. The global NIDDM epidemic. Treating the disease and ignoring the symptoms
4. Diabetes in adults is now a Third World problem
5. The rising global burden of diabetes and its complications: Estimates and projections to the year 2010
6. Type 2 diabetes mellitus in minority children and adolescents. An emerging problem
7. Type II diabetes mellitus: No longer just adults
8. Emerging epidemic of type 2 diabetes in youth
9. Increased incidence of non-insulin-dependent diabetes mellitus among adolescents
10. Characteristics of youth-onset non-insulin-dependent diabetes mellitus and insulin-dependent diabetes mellitus at diagnosis
11. Early presentation of type 2 diabetes in Mexican-American youth
12. Non-insulin-dependent diabetes mellitus in childhood and adolescence
13. Type 2 diabetes among North American children and adolescents: An epide-miologic review and a public health perspective
14. NIDDM-Y in first nation children in Canada
15. Incidence and prevalence of diabetes in children aged 0-14 years in Manitoba, Canada, 1985-1993
16. Risk factors for diabetes and cardiovascular disease in young Australian Aborigines
17. Obesity, albuminuria and hypertension among Hong Kong Chinese with non-insulin-dependent diabetes mellitus (NIDDM)
18. Type 2 diabetes mellitus in UK children - An emerging problem
19. Incidence of insulin-dependent diabetes (IDDM) and non-insulin-dependent diabetes (NIDDM) (0-34 years at onset) in Benghazi, Libya
20. Increased incidence of non-insulin dependent diabetes mellitus among Japanese schoolchildren correlates with an increased intake of animal protein and fat
21. Early presentation of type 2 diabetes mellitus in young New Zealand Maori
22. Descriptive epidemiology of non-insulin dependent diabetes mellitus detected by urine glucose screening in school children in Japan
23. Prevalence of diabetes in a suburban population of Bangladesh
24. Type 2 diabetes in children and adolescents
25. Insulin secretion, insulin sensitivity and diabetes in Black children
26. Type 2 diabetes mellitus in children: Pathophysiology and risk factors
27. A weighty problem - Diagnosis and treatment of type 2 diabetes in adolescents
28. Diabetic ketoacidosis among obese African-American adolescents with NIDDM
29. Pathogenic factors of glucose intolerance in obese Japanese adolescents with type 2 diabetes
30. Diabetic ketoacidosis in young obese Japanese men
31. C-peptide and glucagon profiles in minority children with type 2 diabetes mellitus
32. Insulin resistance and defective glucose insulin coupling in ketosis-prone type 2 diabetes in African-Americans
33. Hyperglycemia and microvascular and macrovascular disease in diabetes
34. Accelerated complications in type 2 diabetes mellitus: The need for greater awareness and earlier detection
35. Non-insulin-dependent diabetes mellitus in Indian children in Manitoba
36. Type 2 diabetes in Pima Indian children: Cardiovascular risk factors at diagnosis and 10 years later
37. The type 2 family. A setting for development and treatment of adolescent type 2 diabetes mellitus
38. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
39. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study
40. Treatment of type 2 diabetes in youth: An argument for randomized controlled studies
41. Type 2 diabetes mellitus in children and adolescence: A primer
42. Treatment of type 2 diabetes mellitus in children and adolescents
43. Metformin improves glycemic control in children with type 2 diabetes
44. Increasing prevalence of type 2 diabetes in American Indian children
45. The public health epidemiology of type 2 diabetes in children and adolescents: A case study of American Indian adolescents in the Southwestern United States
46. Prevalence and incidence of insulin-dependent diabetes
47. Was there an epidemic of diabetes in nonwhite adolescents in Allegheny County, Pennsylvania?
48. Islet cell auto-immunity in White and Black children and adolescents with IDDM
49. Can clinical characteristics predict the absence of islet cell antibodies (Abs) in Black youngsters diagnosed with IDDM?
50. Obese children with insulin-treated diabetes: Is it Type 1 or Type 2?
51. Emergence of type 2 diabetes mellitus in children: Epidemiological evidence
52. Early detection of undiagnosed diabetes mellitus: A US perspective
53. Undiagnosed NIDDM clinical and public health issues
54. Widening awareness of hyperglycemia unawareness
55. Insulin resistance is central to the burden of diabetes
56. Insulin resistance or insulin deficiency: Which is the primary cause of NIDDM?
57. Insulin resistance is not central to the burden of diabetes
58. Glucose intolerance in obese adolescents with polycystic ovary syndrome: Roles of insulin resistance and β-cell dysfunction and risk of cardiovascular disease
59. Banting Lecture: Insulin action, diabetogenes, and the cause of type II diabetes
60. The genetics of NIDDM: An update
61. Challenges in diabetes epidemiology. From west to the rest
62. Epidemiology of NIDDM in non-Europids
63. Glucose and free fatty acid metabolism in human obesity. Relationship to insulin resistance
64. Central obesity: Measurement and metabolic effects
65. Insulin sensitivity, lipids and body composition in children: Is 'syndrome X' present?
66. Metabolic impact of obesity in childhood
67. Visceral fat, insulin sensitivity, and lipids in prepubertal children
68. Central adiposity and its metabolic correlates in obese adolescent girls
69. Health consequences of obesity in youth: Childhood predictors of adult disease
70. Overweight children and adolescents: Description, epidemiology, and demographics
71. Preventing and Managing the Global Epidemic. Report of a WHO consultation
72. The changing lifestyle in the world. Body weight and what else?
73. Obesity, insulin resistance and diabetes - A worldwide epidemic
74. Relation between consumption of sugar-sweetened drinks and childhood obesity: A prospective observational analysis
75. Changes in children's total fat intakes and their food group sources of fat, 1989-91 versus 1994-95: Implications for diet quality
76. Comparative advantage of 3-day food records over 24-hour recall and 5-day food frequency validated by observation of 9- and 10-year-old girls
77. Longitudinal changes in physical activity in a biracial cohort during adolescence
78. Prevalence of diabetes mellitus and impaired glucose tolerance among second-generation Japanese American men
79. Ethnic differences in susceptibility to non-insulin-dependent diabetes. A comparative study of two urbanized Micronesian populations
80. Weight as a risk factor for clinical diabetes in women
81. A prospective study of exercise and incidence of diabetes among US male physicians
82. Physical activity and incidence of non-insulin-dependent mellitus in women
83. Influence of nutritional factors on prevalence of diabetes
84. Insulin sensitivity in African-American children with and without family history of type 2 diabetes
85. Diabetes mellitus in the Pima Indians: Incidence, risk factors and pathogenesis
86. Insulinemia in children at low and high risk of NIDDM
87. Hyperinsulinaemia in youth is a predictor of type 2 (non-insulin-dependent) diabetes mellitus
88. Black-white contrasts in insulin levels during pubertal development. The Bogalusa Heart Study
89. Relation of percentage of body fat and maximal aerobic capacity to risk factors for atherosclerosis and diabetes in black and white seven- to eleven-year-old children
90. Differences in the in vivo insulin secretion and sensitivity in healthy black versus white adolescents
91. Insulin secretion and sensitivity in black versus white prepubertal healthy children
92. Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study
93. Diabetes mellitus: A thrifty genotype rendered detrimental by 'progress'?
94. Circadian rhythms regulate the expression of the thrifty genotype/phenotype
95. The pattern of basal and stimulated insulin responses to intravenous glucose in first degree relatives of type 1 (insulin-dependent) diabetic children and unrelated adults aged 5 to 50 years
96. Changes in serum insulin concentration during puberty and their relationship to growth hormone
97. Impaired insulin action in puberty
98. Correlations between fatty acid and glucose metabolism. Potential explanation of insulin resistance of puberty
99. Insulin resistance during puberty
100. Increased insulin secretion in puberty: A compensatory response to reductions in insulin sensitivity
101. Gonadal steroid hormone regulation of the somatotropic axis during puberty in humans: Mechanisms of androgen and estrogen action
102. GH treatment in adolescents with non-GH deficient short stature (NGHD-SS): Physical, biochemical and metabolic changes
103. Testosterone treatment in adolescents with delayed puberty: Changes in body composition, protein, fat, and glucose metabolism
104. Dihydrotestosterone treatment in adolescents with delayed puberty: Does it explain insulin resistance of puberty?
105. Role of insulin resistance in human disease
106. Acanthosis nigricans as a risk factor for non-insulin dependent diabetes mellitus
107. A quantitative scale of acanthosis nigricans
108. Prevalence of acanthosis nigricans in an unselected population
109. Insulin resistance and the polycystic ovary syndrome. Mechanism and implications for pathogenesis
110. Polycystic ovary syndrome (PCOS): Arguably the most common endocrinopathy is associated with significant morbidity in women
111. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome. A prospective, controlled study in 254 affected women
112. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome
113. Early metabolic abnormalities in adolescent girls with polycystic ovarian syndrome